from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0402c/mmpL1

LFCtreatmentdescriptionclass of inhibitor

-0.684

Amikacinug/mL Amikacintranslation

-0.651

Cap5-10ug/mL Capreomycintranslation

-0.620

Rox10-50 ug/mL Roxithromycintranslation

0.577

SM2-5 ug/mL Streptomycintranslation

0.755

Tet5-10 ug/mL Tetracyclinetranslation

0.308

Rif0.2-5ug/mL Rifampicintranscription

0.320

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.309

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.439

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.287

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.971

Clofazimine10-13 ug/mL Clofaziminerespiration

0.060

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.403

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.158

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.603

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.153

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.341

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.769

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.580

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.166

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.576

Nigericin50 uM Nigericinrespiration

-0.326

TRC10-150 ug/mL Triclosanrespiration

-1.317

TRZ10-25 ug/mL Thioridazinerespiration

-0.854

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.549

menadione6-10 ug/mL Menadionerespiration

0.131

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.757

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.625

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.871

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.662

NRP_1Non-replicating persistence stage 1dosRassociated

0.633

Amp0.2mg/mL AmpicillincellWall

0.497

Cephalexin20-100 ug/mL CephalexincellWall

0.450

Cerulenin0.32-5 ug/mL CerulenincellWall

0.915

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.439

EMB10-20 ug/mL EthambutolcellWall

0.085

Eta12-40 ug/mL EthionamidecellWall

-0.093

INH0.2-0.4 ug/mL IsoniazidcellWall

0.166

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.343

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.638

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.070

BZA0.12 mg/mL BenzamidearomaticAmides

0.214

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.103

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.175

H2O24 mM hydrogen peroxideDNAdamaging

0.432

Levo10 ug/mL LevofloxacinDNAdamaging

0.547

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.119

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.135

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.100

UVUV-irradiationDNAdamaging

-0.865

ARP41-4 ug/mL Antitubercular compound ARP4?

0.383

Antimycin12.5-50 ug/mL Antimycin A?

1.080

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.108

PA_110-50 ug/mL Antitubercular compound PA-1?

0.351

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.114

PA8240.2-2 ug/mL PA-824?

-1.413

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.401

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.046

Verapamil50 uM Verapamil?

0.493

mercaptoethanol2 mM 2-Mercaptoethanol?

0.910

methoxatin10-20 ug/mL Methoxatin?